The In Vitro diagnostic medical devices regulation that will apply as from 26 May 2022, can now be progressively rolled out, thanks to its adoption by the European Parliament and the Council. In the context of the COVID-19 pandemic Member States, health institutions and economic operators redeployed financial and other resources to address the unprecedented…
The European Commission has approved its seventh Advanced Purchase Agreement (APA) with a pharmaceutical company to ensure access to a potential vaccine against COVID-19 in Q4 of 2021 and in 2022. Under this contract, Member States will be able to purchase up to 100 million doses of the Novavax vaccine, with an option for 100…
Parliament and Council negotiators reached on Thursday a provisional deal for an EU digital Covid certificate to facilitate free movement in Europe during the pandemic. The certificate will be available in either digital or paper format. It will attest that a person has been vaccinated against coronavirus or has a recent negative test result or…
The European Commission has signed a third contract with the pharmaceutical companies BioNTech and Pfizer. It reserves an additional 1.8 billion doses on behalf of all EU Member States, between end 2021 to 2023. It will allow for the purchase of 900 million doses of the current vaccine and of a vaccine adapted to variants,…
Ascertaining the origins of SARS-CoV-2, the virus that causes COVID-19, is vital in order to address the current pandemic and reduce the risk of future ones. Although we may never be able to conclusively determine the coronavirus pandemic’s origins, it is nevertheless critical that we make every possible effort to do so. That is why…
